España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Collegium Pharmaceutical
COLL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$29.06
-0.09
-0.31%
At close: -
$29.06
0.00
0.00%
After Hours: 1:00 PM EDT
Get Report
Comment
Collegium Pharmaceutical (COLL) Forecast
News
Earnings
Collegium Pharmaceutical (COLL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Collegium Pharmaceutical (NASDAQ:COLL) Stock
Collegium Pharmaceutical Stock (NASDAQ: COLL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
COLLEGIUM PHARMACEUTICAL Announced That Healt...
Benzinga Newsdesk
Thursday, November 07, 2024
Collegium Names Vikram Karnani As CEO, Effect...
Benzinga Newsdesk
Collegium Pharmaceutical Raises FY2024 Sales ...
Benzinga Newsdesk
Collegium Pharmaceutical Q3 Adj $1.61 Beats $...
Benzinga Newsdesk
Wednesday, November 06, 2024
A Preview Of Collegium Pharmaceutical's Earnings
Benzinga Insights
Friday, October 11, 2024
Piper Sandler Reiterates Neutral on Collegium...
Benzinga Newsdesk
Wednesday, September 18, 2024
Collegium Pharmaceutical Insider Trades Send A Signal
Benzinga Insights
Thursday, September 05, 2024
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
The Analyst Landscape: 4 Takes On Collegium Pharmaceutical
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Collegiu...
Benzinga Newsdesk
Friday, August 09, 2024
The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts
Benzinga Insights
Piper Sandler Reiterates Neutral on Collegium...
Benzinga Newsdesk
Truist Securities Maintains Buy on Collegium ...
Benzinga Newsdesk
Needham Reiterates Hold on Collegium Pharmace...
Benzinga Newsdesk
Thursday, August 08, 2024
Collegium Pharmaceutical Sees 2024 Net Produc...
Benzinga Newsdesk
Collegium Pharmaceutical Q2 2024 Adj. EPS $1....
Benzinga Newsdesk
Tuesday, July 30, 2024
Collegium Pharmaceutical shares are trading h...
Benzinga Newsdesk
HC Wainwright & Co. Upgrades Collegium Pharma...
Benzinga Newsdesk
Needham Reiterates Hold on Collegium Pharmace...
Benzinga Newsdesk
Monday, July 29, 2024
Collegium Pharmaceutical Agrees To Acquire Ir...
Benzinga Newsdesk
Thursday, June 13, 2024
Collegium Pharmaceutical Announces FDA Grant ...
Benzinga Newsdesk
Friday, June 07, 2024
Jefferies Upgrades Collegium Pharmaceutical t...
Benzinga Newsdesk
Monday, May 13, 2024
Collegium Announces $35M Accelerated Buyback ...
Benzinga Newsdesk
Friday, May 10, 2024
Collegium Pharmaceutical shares are trading l...
Benzinga Newsdesk
Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
Benzinga Insights
Needham Downgrades Collegium Pharmaceutical t...
Benzinga Newsdesk
Piper Sandler Downgrades Collegium Pharmaceut...
Benzinga Newsdesk
Thursday, May 09, 2024
Collegium Board Authorizes $35M Accelerated S...
Benzinga Newsdesk
Collegium Reaffirms FY24 Guidance For Product...
Benzinga Newsdesk
Collegium Pharmaceutical Q1 2024 Adj EPS $1.4...
Benzinga Newsdesk
Collegium Says Joe Ciaffoni Will Step Down As...
Benzinga Newsdesk
Monday, April 29, 2024
Collegium Announces Authorized Generic Agreem...
Benzinga Newsdesk
Thursday, April 11, 2024
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
Benzinga Insights
Needham Reiterates Buy on Collegium Pharmaceu...
Benzinga Newsdesk
Monday, February 26, 2024
Truist Securities Maintains Buy on Collegium ...
Benzinga Newsdesk
Friday, February 23, 2024
Where Collegium Pharmaceutical Stands With Analysts
Benzinga Insights
Thursday, February 22, 2024
Collegium Reaffirms Its Full-year 2024 Guidan...
Benzinga Newsdesk
Recap: Collegium Pharmaceutical Q4 Earnings
Benzinga Insights
Collegium Pharmaceutical Q4 2023 Adj EPS $1.5...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Friday, February 02, 2024
Analyst Expectations For Collegium Pharmaceutical's Future
Benzinga Insights
Needham Reiterates Buy on Collegium Pharmaceu...
Benzinga Newsdesk
Thursday, January 04, 2024
Needham Maintains Buy on Collegium Pharmaceut...
Benzinga Newsdesk
Truist Securities Maintains Buy on Collegium ...
Benzinga Newsdesk
Jefferies Downgrades Collegium Pharmaceutical...
Benzinga Newsdesk
Wednesday, January 03, 2024
Collegium Pharmaceutical shares are trading h...
Benzinga Newsdesk
Why Collegium Pharmaceutical Shares Are Gaining Today
Akanksha Bakshi
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Collegium Board Approves Up To $150M Share Re...
Benzinga Newsdesk
Collegium Sees 2024 Net Product Revenues In R...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch